New FDA guidance documents

被引：0

|

作者：

Bradshaw, Sheldon T. ^{[1
]}

机构：

[1] US FDA, Rockville, MD 20857 USA

来源：

FOOD AND DRUG LAW JOURNAL | 2007年 / 62卷 / 02期

关键词：

D O I：

暂无

中图分类号：

TS2 [食品工业];

学科分类号：

0832 ;

摘要：

引用

收藏

页码：429 / 431

页数：3

相关论文

共 50 条

[41] FDA Gives Drug Codevelopment Guidance
不详
CANCER DISCOVERY, 2013, 3 (10) : 1087 - +
[42] FDA Issues Guidance on Biosimilar Labeling
Haigney, Susan
BIOPHARM INTERNATIONAL, 2023, 36 (11) : 24 - 24
[43] FDA guidance on foreign clinical studies
不详
JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 35N - 35N
[44] FDA unveils guidance for biosimilar development
Wechsler, Jill
FORMULARY, 2012, 47 (03) : 96 - 96
[45] Opportunities for enhancing the FDA guidance on pharmacovigilance
Psaty, Bruce M.
Vandenbroucke, Jan P.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (08): : 952 - 954
[46] FDA issues nanotech draft guidance
Nachay, Karen
FOOD TECHNOLOGY, 2012, 66 (06) : 16 - 16
[47] FDA Publishes Guidance on ANDA Submissions
不详
BIOPHARM INTERNATIONAL, 2014, 27 (08) : 8 - 8
[48] FDA's draft guidance on pharmacogenomics
Hellman, K
Smith, D
GENETIC ENGINEERING NEWS, 2005, 25 (04): : 18 - +
[49] FDA Draft Guidance on the Naming of Biosimilars
Fernandez-Lopez, Sara
BIODRUGS, 2015, 29 (05) : 323 - 325
[50] FDA draft guidance on compounding and repackaging
Reactions Weekly, 2015, 1540 (1) : 2 - 2

← 1 2 3 4 5 →